Clinical Trials Sponsored by Cordio Medical

Total 56607 results

Cordio Medical

Recruiting

COMMUNITY STUDY- A Study to Collect Information for the Cordio System

Heart Failure

Israel
Cordio Medical

Completed

Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients

Coronavirus Infection

Israel
Cordio Medical

Completed

Clinical Evaluation of Cordio App in Adult ADHF Patients

Congestive Heart Failure

Israel
Cordio Medical

Recruiting

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM (DETECT-HF)

Heart Failure

United States, Israel
Cordio Medical

Recruiting

R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances

Chronic Heart Failure

United States, Israel
Cordio Medical

Completed

Remote Speech Analysis in HF Patients Undergoing Haemodialysis

Heart Failure

Israel
Corvia Medical

Recruiting

REDUCE LAP-HF III Corvia Protocol 1701 (REDUCELAPHFIII)

Heart Failure

Germany, Switzerland
Corvia Medical

Active, not recruiting

REDUCE LAP-HFREF TRIAL

Heart Failure

Australia, United States, Czechia
Corvia Medical

Active, not recruiting

REDUCE LAP-HF RANDOMIZED TRIAL I

Heart Failure

United States, Netherlands, Australia, Belgium, United Kingdom
Corvia Medical

Withdrawn

Extended IASD Investigation: REDUCE LAP-HF IV

Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection Fraction
Corvia Medical

Recruiting

RESPONDER-HF Trial

Heart Failure | Heart Failure, Diastolic

United States, Germany, Australia, Netherlands, Belgium, Austria
Cardio Med Medical Center

Completed

Multiomics and Imaging-based Assessment of Vulnerable Coronary Plaques in Acute Coronary Syndromes (MultiPlaque)

Atherosclerosis | Acute Coronary Syndrome | Coronary Stenosis | Acute Myocardial Infarction | Unstable Angina | Atheromatous Plaques | Non-ST Elevation Myocardial Infarction

Romania
Cordis Corporation
Ensure Medical

Completed

Plug Arterial Closure System (PACS, 7F) (PACS 7F)

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Mexico
Corvia Medical

Active, not recruiting

REDUCE LAP-HF TRIAL II

Heart Failure

United States, Austria, Japan, Australia, Netherlands, Canada, France, Denmark, Germany, Spain, Italy, Belgium, Croatia, Poland, United Kingdom
Corvia Medical

Completed

Feasibility Trial of the DC Devices Interatrial Septal Device (IASD) System

Heart Failure

Denmark, Australia, Czechia
Corvia Medical

Completed

REDUCE LAP-HF TRIAL (REDUCE LAP-HF)

Heart Failure

New Zealand, Austria, France, Denmark, Germany, Netherlands, United Kingdom, Australia, Czechia, Belgium, Poland
Cardio Flow, Inc.
Libra Medical

Completed

Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease (FASTII)

Peripheral Arterial Disease

United States
Cardio Flow, Inc.
Libra Medical

Completed

Feasibility Clinical Trial of the Cardio Flow Orbital Atherectomy System to Treat Peripheral Artery Disease (PAD) (FAST)

Peripheral Arterial Disease

United States
Cordis Corporation

Completed

A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION) (INNOVATION)

Abdominal Aortic Aneurysms

Germany
Cordis Corporation

Completed

SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy

Carotid Artery Disease

United States
Cordis Corporation

Unknown

Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems (ELITE)

Coronary Artery Disease | Coronary Atherosclerosis

United States
Cordis Corporation

Terminated

Cynergy: the CYPHER-NEVO Registry (CYNERGY)

Coronary Artery Disease

Korea, Republic of, Brazil, Switzerland
Cordis Corporation

Completed

Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease (ACHILLES)

Peripheral Arterial Diseases

Germany
Cordis Corporation

Completed

A Study of the SMART Stent in the Treatment SFA Disease. (SIROCCO)

Peripheral Artery Disease

Germany
Cordis Corporation

Completed

A Multi-center Post-Market Surveillance Registry (E-SELECT)

Coronary Artery Disease

Switzerland
Cordis Corporation

Completed

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

In-Stent Restenosis

United States
Cordis Corporation

Completed

The Study to Compare SMART Nitinol Stent and Balloon Angioplasty (SIT-UP)

Superficial Femoral Artery Occlusions

Switzerland
Cordis Corporation

Completed

The Study to Treat Superficial Femoral Artery Occlusions. (SUPER UK)

Arterial Occlusive Diseases

United Kingdom
Cordis Corporation

Completed

The Arterial Revascularization Therapies Study Part II. (ARTS II)

Coronary Artery Disease

Netherlands
Cordis Corporation

Completed

Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)

Abdominal Aortic Aneurysm

United States
Cordis Corporation

Terminated

The Study to Compare the Treatment of Angioplasty and Stents in SFA Occlusions. (DURAVEST)

Arterial Occlusive Diseases

Netherlands
Cordis Corporation

Completed

The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity. (DISCOVER)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions. (DOMINO)

Coronary Artery Disease

United Kingdom
Cordis Corporation

Completed

A Comparison of Coated and Uncoated Stents in Renal Artery Treatment. (GREAT)

Renal Artery Stenosis

France, Germany, Netherlands
Cordis Corporation

Completed

A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions. (TROPICAL)

Coronary Artery Disease

Belgium, Germany
Cordis Corporation

Completed

A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions. (BIFURCATION)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)

Coronary Artery Disease
Cordis Corporation

Completed

FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent

Coronary Artery Disease

France
Cordis Corporation

Completed

Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus

Coronary Artery Disease

France
Cordis Corporation

Withdrawn

China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)

Abdominal Aortic Aneurysms

China
Cordis Corporation

Unknown

CYPRESS - CYPHER for Evaluating Sustained Safety

Coronary Artery Disease

United States
Cordis Corporation

Completed

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary | Peripheral Arteriosclerosis

United States
Cordis Corporation

Completed

ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU (ECLIPSE)

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Germany
Cordis Corporation

Terminated

French Post-Marketing Surveillance Survey (FR E-REGISTRY)

Coronary Artery Disease
Cordis Corporation

Completed

A Study of the Presillion Stent in de Novo Coronary Lesions (PRESILLION)

Coronary Artery Disease

Belgium
Cordis Corporation

Completed

NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial (DESSERT)

Coronary Artery Disease

Italy

Clinical Trials Sponsored by Cordio Medical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations